TSC2 and tuberous sclerosis: We show that nephric differentiation of patient-derived, and genetically-edited TSC2−/− hiPSCs but not of isogenic TSC2+/− hiPSCs19, resulted in formation of two-dimensional (2D) and three-dimensional (3D) kidney tissues recapitulating TSC-associated AML and cystic disease.